Rossari Biotech Q1 2026: ₹47 Cr Profit, ₹1,200 Cr Revenue, 28 % Growth
Rossari Biotech’s Q1 2026 earnings saw a 25% profit jump to ₹47 crore and 28% revenue rise to ₹1,200 crore, underscoring strong product mix, sales growth, and a new employee‑stock plan.
2 minutes to read